Start Date

5-15-2025 9:30 AM

End Date

5-15-2025 11:30 AM

Description

Background

  • Problem: There is data on AC/AP use in perioperative period for patients undergoing spine surgery and no formal established guidelines on when to resume AC/AP medications after surgery
  • Aim: To determine standardized protocol for resuming antiplatelet/anticoagulation therapy following lumbar surgery and to reduce combined post-operative cardiac/cerebrovascular/thrombotic events, and post- operative hematomas by 10% in 5 years
  • Population: Patients undergoing elective lumbar spine surgery who take AC/AP at home

Keywords

anticoagulation, perioperative, spine surgery

Comments

Presented at the 2025 Jefferson Health Equity and Quality Improvement (HEQI) Summit.

Share

COinS
 
May 15th, 9:30 AM May 15th, 11:30 AM

Resumption of Anti-Platelet/Anticoagulation Therapy Following Lumbar Spine Surgery

Background

  • Problem: There is data on AC/AP use in perioperative period for patients undergoing spine surgery and no formal established guidelines on when to resume AC/AP medications after surgery
  • Aim: To determine standardized protocol for resuming antiplatelet/anticoagulation therapy following lumbar surgery and to reduce combined post-operative cardiac/cerebrovascular/thrombotic events, and post- operative hematomas by 10% in 5 years
  • Population: Patients undergoing elective lumbar spine surgery who take AC/AP at home